Advertisement
U.S. Markets close in 32 mins

Interpace Biosciences, Inc. (IDXG)

OTC Markets OTCQX - OTC Markets OTCQX Delayed Price. Currency in USD
Visitors trend2W10W9M
2.9500+0.1000 (+3.51%)
As of 03:04PM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
44,893
40,214
31,838
33,117
32,398
Cost of Revenue
17,749
16,310
13,607
14,314
21,673
Gross Profit
27,144
23,904
18,231
18,803
10,725
Operating Expense
20,788
21,093
22,071
24,567
34,702
Operating Income
6,356
2,811
-3,840
-5,764
-23,977
Net Non Operating Interest Income Expense
-782
-1,008
-1,008
-1,040
-549
Other Income Expense
-672
-674
-988
-938
-1,622
Pretax Income
4,902
1,129
-5,836
-7,742
-26,148
Tax Provision
17
17
29
-705
53
Net Income Common Stockholders
4,700
802
-21,958
-14,943
-29,484
Diluted NI Available to Com Stockholders
4,700
802
-21,958
-14,943
-29,484
Basic EPS
-3.59
0.19
-5.18
-3.61
-7.32
Diluted EPS
-3.59
0.18
-5.18
-3.61
-7.32
Basic Average Shares
4,283
4,317
4,238
4,135
4,029
Diluted Average Shares
4,285
4,364
4,238
4,135
4,029
Total Operating Income as Reported
6,349
2,804
-3,617
-6,336
-26,066
Total Expenses
38,537
37,403
35,678
38,881
56,375
Net Income from Continuing & Discontinued Operation
4,700
802
-21,958
-14,943
-26,451
Normalized Income
4,892
1,119
-6,041
-6,529
-24,676
Interest Expense
782
1,008
1,008
1,040
549
Net Interest Income
-920
-1,008
-1,008
-1,040
-549
EBIT
5,684
2,137
-4,828
-6,702
-25,599
EBITDA
6,407
3,738
-1,326
-1,328
-20,098
Reconciled Cost of Revenue
17,053
15,570
11,375
12,132
20,633
Reconciled Depreciation
723
1,601
3,502
5,374
5,501
Net Income from Continuing Operation Net Minority Interest
4,885
1,112
-5,865
-7,037
-26,201
Total Unusual Items Excluding Goodwill
-7
-7
223
-559
-2,089
Total Unusual Items
-7
-7
223
-559
-2,089
Normalized EBITDA
6,414
3,745
-1,549
-769
-18,009
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-0.0243
-0.105
46.83
-50.869
-564.03